Skip to main content
SpringerLink
Log in

Impact of Janusmed Risk Profile on AEs in older patients receiving polypharmacy

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Pharmacological Risk Assessment Among Older Patients with Polypharmacy Using the Clinical Decision Support System Janusmed Risk Profile: A Cross-Sectional Register Study Drugs and Aging : 11 Apr 2023. Available from: URL: https://doi.org/10.1007/s40266-023-01021-9

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Impact of Janusmed Risk Profile on AEs in older patients receiving polypharmacy. Reactions Weekly 1954, 9 (2023). https://doi.org/10.1007/s40278-023-37827-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-37827-0

Search

Navigation